Customer concentration
Two customers accounted for 31% and 10% of fiscal 2025 sales, so order changes by a few accounts can materially affect revenue and profitability.
- Scope
- Top customers and top ten customer base
- Materiality
- high
Cyanotech Corp is a U.S.-based producer of microalgae-derived nutritional ingredients and finished supplements, built around Hawaiian Spirulina Pacifica and BioAstin Hawaiian Astaxanthin. The company grows, harvests, processes, and sells spirulina and astaxanthin in bulk form to ingredient customers and in packaged consumer form through its Nutrex Hawaii subsidiary. It also monetizes its extraction expertise through contract extraction services and, more recently, third-party R&D services. Cyanotech’s business is tied to its Kona, Hawaii production site, where climate, cultivation conditions, and production volume directly affect output, quality, and margins.
−4,2 %
28,4 %
−13,2 %
+5,0 %
1.03
0.27
| % | |
|---|---|
| Bulk spirulina ingredients | 30% Hawaiian Spirulina Pacifica sold as powder or tablets to manufacturers and formulators. |
| Bulk astaxanthin ingredients | 40% BioAstin-related astaxanthin sales in bulk form for use in customer products. |
| Packaged consumer supplements | 23% Finished spirulina and astaxanthin products sold through retail, online, and distributor channels. |
| Contract extraction services | 4% Supercritical CO2 extraction services provided to third-party biomass producers. |
| Research and development services | 3% Microalgae-related R&D services offered to third parties using excess capacity and know-how. |
Cyanotech sells bulk ingredients primarily to international health food manufacturers, formulators, and other producers...
Buy spirulina and astaxanthin ingredients to incorporate into their own health and nutrition products, often because they value Hawaiian sourcing and product quality.
Purchase finished spirulina and astaxanthin products through retail, e-commerce, and direct channels for wellness and nutritional use.
Distribute Cyanotech-branded or customer-branded products in selected overseas markets where local channel partners are used.
Third-party biomass producers that outsource extraction to Cyanotech’s supercritical CO2 system.
Third parties seeking microalgae cultivation and processing expertise for development work.
Cyanotech is headquartered and produces in Hawaii, with its core cultivation and processing operations centered at its...
Cyanotech’s current strategy is to stabilize operations and improve cash generation while focusing on higher-margin...
The business has high fixed agricultural costs, so matching output to demand is essential to protect cash and margins.
Premium branded supplements can support better economics than commodity-like bulk sales.
Contract extraction and R&D services can generate incremental revenue from existing assets and know-how.
Cyanotech faces meaningful customer concentration risk because a small number of customers account for a large share of...
Two customers accounted for 31% and 10% of fiscal 2025 sales, so order changes by a few accounts can materially affect revenue and profitability.
Microalgae cultivation depends on weather, temperature, nutrients, water, and contamination control, making output and cost absorption volatile.
The company competes with larger supplement producers and spirulina farms in India and China that may have greater scale or lower costs.
FDA, FTC, state health, agriculture, and environmental rules can increase costs and constrain operations or marketing claims.
Order processing, billing, shipping, and customer support depend on information systems that could be disrupted by a breach.
UCFI · Food and Kindred Products
CNBX · Pharmaceutical Preparations
CELU · Pharmaceutical Preparations
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
CTMX · Pharmaceutical Preparations
CytomX Therapeutics is a clinical-stage biopharmaceutical company built around its PROBODY platform, which masks biologic drug activity until it reaches the tumor microenvironment.
MTEX · Medicinal Chemicals & Botanical Products
: 28/04/2026